CGT Flow Cytometry Fundamentals – Grasp how conventional and spectral platforms quantify CAR-T identity, purity, and potency throughout manufacturing and clinical use.
CAR-T Immunophenotyping Mastery – Confidently interpret lineage and activation markers that define product quality and predict in-vivo performance.
Regulatory-Grade Gating & Validation – Design CLSI H62-aligned assays with MIFlowCyt documentation, CLIA/CAP compliance, and FDA-ready data packages for IND or BLA filings.
Potency & Cytotoxicity Insight – Apply flow-based cytotoxicity and functional readouts that correlate with clinical outcomes and immune-kinetic profiles.
Error-Proof Workflows – Detect and correct technical pitfalls—from spectral overlap to MRD sensitivity limits—before they compromise trial results.
End-to-End Immunomonitoring Skills – Build panels that track persistence, exhaustion, and minimal residual disease across the full span of a clinical study.